Beryl Drugs Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 524606

₹24.84

Oct. 5, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #173 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Beryl Drugs Ltd. (this stock)	13	20.0	6.5%	-29.8%	—	49	84	52

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹15 Cr

EV / EBITDA

5.8x

EV / Sales

0.69x

Market cap / Sales

0.59x

Earnings yield

4.99%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 8 Cr, up 56.5% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 0 Cr, up 952.4% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	7	0	0	₹0.4400
March 31, 2026	5	1	1	₹1.1100
Dec. 31, 2025	4	-1	—	₹-0.3300
Sept. 30, 2025	5	0	0	₹0.0200
June 30, 2025	5	0	0	₹0.0400
March 31, 2025	4	0	—	₹0.3000
Dec. 31, 2024	5	0	0	₹0.1000
Sept. 30, 2024	6	0	0	₹0.0100
June 30, 2024	6	0	0	₹0.7300
March 31, 2024	3	-0	-0	₹-0.6800
Dec. 31, 2023	8	0	0	₹0.6100
Sept. 30, 2023	8	0	0	₹0.5400
June 30, 2023	8	1	1	₹1.0500

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	8	5	4	5	5	5	5	6	6	3	8	8	8
Operating revenue	7	5	4	5	5	4	5	6	6	3	8	8	8
Other income	0	0	0	0	0	1	0	0	0	0	0	0	0
Operating expenses	7	4	4	4	4	5	5	5	5	3	7	7	7
Operating profit	0	1	-0	1	1	-1	0	1	1	-0	1	1	1
Operating profit margin	5.2%	19.5%	-7.2%	13.6%	10.6%	-18.8%	9.4%	9.5%	15.1%	-6.9%	10.0%	8.2%	13.2%
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	0	1	-1	0	0	0	0	0	0	-0	0	0	1
Tax	0	0	-0	0	0	-0	0	0	0	-0	0	0	0
Net profit	0	1	—	0	0	—	0	0	0	-0	0	0	1
EPS	0.44	1.11	-0.33	0.02	0.04	0.30	0.10	0.01	0.73	-0.68	0.61	0.54	1.05
Net profit (TTM)	—	—	—	—	—	—	0	0	1	1	1	1	1
EPS (TTM)	1.24	0.84	0.03	0.46	0.45	1.14	0.16	0.67	1.20	1.52	2.32	1.99	2.12

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	-10.7%	6.2%	19^†	23^†	27^†	27^†	15^†	14^†	13^†	16^†	—
Operating revenue	-11.2%	6.0%	19^†	21^†	27^†	27^†	15^†	14^†	13^†	15^†	11^†
Other income	—	—	0^†	1^†	0^†	0^†	0^†	0^†	0^†	1^†	—
Operating expenses	—	—	17^†	20^†	24^†	25^†	14^†	13^†	12^†	14^†	10^†
Operating profit	-0.2%	6.0%	2^†	1^†	2^†	2^†	0^†	1^†	1^†	1^†	1^†
Operating profit margin	—	—	10.3%^†	5.8%^†	8.5%^†	7.2%^†	2.8%^†	10.3%^†	8.3%^†	6.5%^†	7.1%^†
Depreciation	—	—	1^†	1^†	1^†	1^†	1^†	1^†	0^†	0^†	0^†
Interest	—	—	0^†	1^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	-15.8%	11.1%	1^†	1^†	1^†	1^†	-1^†	0^†	1^†	1^†	0^†
Tax	—	—	0^†	0^†	0^†	0^†	-0^†	0^†	0^†	0^†	—
Net profit	—	—	—	—	1^†	1^†	-1^†	0^†	1^†	1^†	0^†
EPS	-17.6%	12.8%	0.84^†	1.14^†	1.52^†	1.50^†	0.36^†	0.46^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Operating margin	10.3%^†	5.8%^†	8.5%^†	7.2%^†	2.8%^†	10.3%^†	8.3%^†	6.5%^†	7.1%^†
EBIT margin	5.0%^†	6.6%^†	5.5%^†	5.2%^†	-3.5%^†	5.8%^†	7.7%^†	8.9%^†	3.5%^†
PBT margin	3.1%^†	4.1%^†	3.8%^†	3.7%^†	-6.5%^†	2.5%^†	6.1%^†	8.1%^†	1.6%^†
Net margin	—	—	2.9%^†	2.8%^†	-4.5%^†	1.7%^†	4.6%^†	6.5%^†	1.0%^†
Interest coverage	2.71x^†	2.64x^†	3.18x^†	3.37x^†	-1.17x^†	1.75x^†	4.95x^†	10.28x^†	1.85x^†
Dividend payout	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—
Current ratio	1.55x	2.10x	—	—	—	—	—	—	—
Quick ratio	0.86x	1.66x	—	—	—	—	—	—	—
Debt to equity	0.24x	0.43x	—	—	—	—	—	—	—
Return on equity	—	—	—	—	—	—	—	—	—
Return on assets	—	—	—	—	—	—	—	—	—
Return on capital employed	8.9%^†	12.0%^†	—	—	—	—	—	—	—
Asset turnover	1.26x^†	1.32x^†	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	4	-2	-2	4	-0
March 31, 2025	3	-0	-2	2	0

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	15	10	5	2	0	7	5	0	7	3
March 31, 2025	16	10	4	2	2	9	4	1	6	2

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.